Exergame and Robotic Therapy Impact on Tenascin-C and Functional Outcome on Stroke Patients
Comparison of Tenascin-C Value Rates and Functional Outcomes Between Exergame Therapy and Robotic Therapy in Post-Stroke Patients
1 other identifier
interventional
48
1 country
2
Brief Summary
This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are: 1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 17, 2024
CompletedFirst Posted
Study publicly available on registry
August 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedAugust 20, 2024
August 1, 2024
1.2 years
August 17, 2024
August 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score
a motoric assessment with each score range from 0-2 with a total score range from 0-66. Higher score indicates better and free movement
changes of FMA-UE score from pre-intervention to six weeks after intervention
Nine Hole Peg Test Value
an assessment for finger dexterity and coordination where the time of the subject to accomplish task will be recorded. Average healthy adult male completed the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand. For healthy adult women, the NHPT was completed in 17.9 seconds (SD 2.8) and 19.6 seconds (SD 3.4) with the right and left hands, respectively.
changes of NHPT values from pre-intervention to six weeks after intervention
Handgrip Dynamometer value
The handgrip dynamometer measures hand strength, with a typical range of 0 to 100 kg (0 to 220 lb). For men, normal handgrip strength usually falls between 30-60 kg (66-132 lb), while for women it ranges from 20-40 kg (44-88 lb).
changes of handgrip values from pre-intervention to six weeks after intervention
Tenascin-C value
The normal range of Tenascin-C levels in healthy individuals typically falls between 50 to 200 ng/mL.
changes of Tenascin-C value from pre-intervention to six weeks after intervention
Study Arms (3)
Standard Rehabilitation/Conventional
ACTIVE COMPARATORThe conventional exercise therapy group will be given diathermic, electricity modality, hydrotherapy, and therapeutic exercises in the form of muscle stretching, strengthening exercises, transfer exercises, walking exercises, and hand function exercises for 3 times a week within 6 weeks.
Exergame
EXPERIMENTALConventional therapy coupled with virtual reality Exergame exercises on the hands for 3 times a week a time 6 weeks
Robotic
EXPERIMENTALconventional therapy coupled with robotic therapy exercises on the hands for 3 times a week a time of 6 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Patients after ischemic or hemorrhagic stroke
- stable hemodynamics and neurologic state.
- Patients have never undergone treatment with any intervention
- Able to watch television with or without glasses from a distance of 1 meter.
- Patients can understand informed consent to participate in research
You may not qualify if:
- Patients with a history of seizures or epilepsy.
- Patients with severe cognitive disorders that can interfere with research objectives (MMSE score \<24).
- Patients with field deficits or severe vision disorders.
- The patient is unable to sit upright without help.
- Patients with significant pain in the affected upper limb.
- Patients with significant sensory decreases in the upper limb that are affected
- Patients with other medical conditions (musculoskeletal, neuromuscular, cardio respiration) are uncontrolled and are at risk of disrupting the ability to exercise.
- Dropout Criteria
- Patients who were declared dead
- Refusing to continue the training session or less \< 50% of all sessions.
- Experiencing hemodynamic and neurological disorders during the training program process.
- Experiencing cybersickness twice in successive training sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hasanuddin University, Faculty of Medicine
Makassar, South Sulawesi, 90245, Indonesia
Wahidin Sudirohusodo General Hospital
Makassar, South Sulawesi, 90245, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rumaisah Hasan, MD
Hasanuddin University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigator will be masked from the allocation as well as outcome assessor
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
August 17, 2024
First Posted
August 20, 2024
Study Start
October 1, 2023
Primary Completion
December 1, 2024
Study Completion
March 1, 2025
Last Updated
August 20, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
No To protect the confidentiality, should the data need to share, any de-identified data will be shared for peer-review